Plasma-derived versus recombinant factor VIII concentrates for the treatment of haemophilia A: plasma-derived is better

被引：0
|
作者：
Mannucci, Pier Mannuccio [1 ]
机构：
[1] Mangiagalli & Regina Elena Fdn, IRCCS Maggiore Hosp, Sci Direct, Milan, Italy
来源：
BLOOD TRANSFUSION | 2010年 / 8卷 / 04期
关键词：
VON-WILLEBRAND-FACTOR; PREVIOUSLY UNTREATED PATIENTS; INHIBITOR DEVELOPMENT; RISK-FACTORS; IN-VITRO; PRODUCTS; EPIDEMIOLOGY; ANTIBODIES; RELEVANCE; PROTECTS;
D O I：
10.2450/2010.0072.10
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：288 / 291
页数：4
相关论文
共 50 条
  • [21] RELATION OF ACTIVATED FACTOR-VIII TO THE POTENCY IN FACTOR-VIII CONCENTRATES, COMPARISON OF PLASMA-DERIVED AN RECOMBINANT FACTOR-VIII
    MINAMIYAMA, T
    ITO, Y
    OGURI, S
    KOBAYASHI, K
    TAKEDA, M
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 942 - 942
  • [22] Comparative effectiveness of plasma-derived and recombinant FVIII concentrates in the on-demand and prophylactic treatment of patients with haemophilia A
    Pollmann, H
    Richter, H
    Siegmund, B
    HAEMOPHILIA, 2004, 10 (05) : 676 - 678
  • [23] Plasma-derived and recombinant FVIII
    Herzog, Roland W.
    BLOOD, 2009, 114 (04) : 753 - 754
  • [24] Changing recombinant factor VIII to plasma-derived factor VIII during immune tolerance induction
    Dias, Maise Moreira
    Camelo, Ricardo Mesquita
    de Magalhaes, Laura Peixoto
    Jardim, Leticia Lemos
    de Oliveira, Andrea Goncalves
    de Albuquerque Ribeiro, Rosangela
    Franco, Vivian Karla Brognoli
    de Araujo Callado, Fabia Michelle Rodrigues
    Lorenzato, Claudia Santos
    Rezende, Suely Meireles
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2024, 41 (01) : 74 - 80
  • [25] Deep viral metagenomics in patients with haemophilia receiving plasma-derived coagulation factor concentrates
    Valenca, Ian Nunes
    Bezerra, Rafael dos Santos
    de Oliveira, Luciana Correa Oliveira
    Covas, Dimas Tadeu
    Kashima, Simone
    Slavov, Svetoslav Nanev
    HAEMOPHILIA, 2021, 27 (05) : E645 - E648
  • [26] The increased demand for plasma-derived factor VIII in Italy
    Arcieri, Romano
    Calizzani, Gabriele
    Candura, Fabio
    Mannucci, Pier Mannuccio
    BLOOD TRANSFUSION, 2017, 15 (03) : 279 - 280
  • [27] RECENT ADVANCES IN THE PREPARATION OF PLASMA-DERIVED AND RECOMBINANT COAGULATION FACTOR-VIII
    BRAY, GL
    JOURNAL OF PEDIATRICS, 1990, 117 (03): : 503 - 507
  • [28] Biochemical and immunochemical investigations of different plasma-derived and recombinant factor VIII products
    Josic, D
    Stadler, M
    Buchacher, A
    Schulz, P
    Schutz, R
    Wiry, G
    Schwinn, H
    THROMBOSIS AND HAEMOSTASIS, 1997, : P2095 - P2095
  • [29] Effect of plasma-derived or recombinant factor VIII on inhibitor development: a systematic review
    Iorio, A.
    Halimeh, S.
    Goldenberg, N.
    Kenet, G.
    Young, G.
    Brandao, L.
    HAEMOPHILIA, 2010, 16 : 74 - 74
  • [30] Native analysis of plasma-derived clotting factor VIII concentrates: "Sponge effect" and contaminants
    Blasi, Barbara
    D'Amici, Gian Maria
    D'Alessandro, Angelo
    Zolla, Lello
    ELECTROPHORESIS, 2012, 33 (08) : 1292 - 1298
12345